Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Status epilepticus

Neurology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

A convulsive seizure continuing for five minutes or more, or repeated seizures without recovery, is status epilepticus and requires immediate treatment. Call for resuscitation and senior help, use ABCDE, time every drug, correct hypoglycaemia and prepare second-line therapy and airway support without waiting for laboratory or EEG confirmation.

Synopsis

Treat convulsive status epilepticus from the five-minute threshold with parallel physiological support and cause correction, escalate promptly after two benzodiazepine doses, and recognise non-convulsive status when consciousness does not recover.

  • Use the operational five-minute threshold because spontaneous termination becomes less likely and neuronal, respiratory, metabolic and systemic injury accumulates as convulsions continue.
  • Protect from injury, position and suction when feasible, give high-concentration oxygen if hypoxaemic, attach monitoring, obtain intravenous or intraosseous access and check capillary glucose immediately.
  • Give first-line benzodiazepine promptly: intravenous lorazepam when resuscitation facilities and access are available, or buccal midazolam or rectal diazepam when they are not, following the individual plan or local protocol.
  • If convulsions continue, a second benzodiazepine dose can be given after the protocol interval; after two adequate doses, move to intravenous levetiracetam, phenytoin or sodium valproate with expert guidance.
  • Do not let repeated small benzodiazepine doses consume the treatment window. Cumulative respiratory depression and failure to progress are common medication errors in prolonged seizures.
  • Refractory status persisting after an appropriate benzodiazepine and second-line medicine needs critical care, anaesthetic treatment and continuous EEG according to a specialist protocol.
  • Search for causes in parallel: non-adherence, stroke, infection, hypoglycaemia, sodium disturbance, alcohol or drug withdrawal, toxicity, eclampsia, trauma and autoimmune encephalitis all require mechanism-specific treatment.
  • For eclampsia, intravenous magnesium sulfate is the first-line anticonvulsant: use the obstetric regimen rather than substituting diazepam, phenytoin or a routine status-epilepticus load.
  • Persistent impaired consciousness after motor activity stops may be postictal, sedative-related or non-convulsive status; serial examination and urgent EEG help distinguish these pathways.

Key red flags

Convulsive status

Continuous generalised convulsive activity at five minutes or recurrent convulsions without meaningful recovery meets the emergency treatment threshold and should be announced with elapsed time.

Subtle ongoing motor activity

Persistent eye deviation, eyelid twitching, facial jerks or rhythmic distal movement after major convulsions stop can represent continuing seizure activity rather than recovery.

Non-convulsive status

Unexplained prolonged confusion, fluctuating responsiveness, behavioural change or coma, especially after a convulsion or in acute brain illness, warrants urgent EEG and neurological review.

Complicated physiology

Hypoxia, hypercapnia, aspiration, hypotension, hyperthermia, acidosis, rhabdomyolysis and hyperkalaemia can emerge during prolonged convulsions and need concurrent resuscitative treatment.

Cause-specific emergency

Fever with meningism, pregnancy-associated hypertension, focal deficit, head trauma, severe hyponatraemia or toxic exposure directs an additional time-critical pathway alongside seizure termination.

Investigation priorities

01
Capillary glucose and immediate physiological monitoringFirst step

Detect a rapidly reversible cause and quantify respiratory and circulatory compromise during treatment.

Management branches

0–10 minutesResuscitate and give benzodiazepine

A convulsive seizure reaches five minutes or repeats without recovery.

  1. 1. Call the emergency team, state seizure duration, protect airway and cervical spine as relevant, monitor ABCDE and check capillary glucose.
  2. 2. Give intravenous lorazepam if access and resuscitation facilities are present, otherwise use buccal midazolam or rectal diazepam according to plan and protocol.
  3. 3. Document drug, dose and exact time, reassess ventilation and circulation, obtain IV or IO access and send urgent cause-directed blood tests.
  4. 4. If seizure activity continues after the specified interval, give one further adequate benzodiazepine dose while preparing second-line therapy and critical-care support.

Key medicines

Intravenous lorazepamA common adult protocol uses 0.1 mg/kg intravenously up to 4 mg, with one repeat dose after 5–10 minutes if convulsions continue; use the current local algorithm.Monitor airway, respiratory rate, oxygenation and blood pressure. Count pre-hospital benzodiazepines before repeating, and do not postpone second-line treatment through serial subtherapeutic dosing.
Intravenous levetiracetamMany UK emergency protocols use 60 mg/kg up to 4.5 g infused over about 10 minutes after two benzodiazepine doses; confirm dose and infusion with the local formulary.Do not delay airway escalation while it infuses. Record renal impairment for subsequent maintenance adjustment and monitor sedation, agitation and clinical or electrographic seizure persistence.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG217 status epilepticus recommendationsNational first-line, repeat-dose and second-line treatment sequence.
  • Resuscitation Council UK 2025 guidelinesCurrent UK ABCDE, airway and advanced resuscitation principles.
  • NICE NG217 treatment safety and monitoringOngoing antiseizure medication, monitoring and emergency-plan principles.
  • MHRA valproate safety measuresCurrent UK regulatory safeguards relevant after emergency valproate use and future prescribing.
  • NICE NG133 eclampsia recommendationsFirst-line magnesium sulfate regimen, recurrent-fit dose and medicines not to substitute for it.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting review
JurisdictionUnited Kingdom